You searched for lung cancer | Page 61 of 172

FDA Approves Agilent’s NSCLC Liquid Biopsy Companion Diagnostic Test

Posted by Andy Lundin | Dec 14, 2022 | Lung Cancer |

Agilent Technologies announced that the FDA has approved the ctDx FIRST as a companion diagnostic to identify advanced NSCLC.

Posted by Andy Lundin | Nov 29, 2022 | Cancer |

As cancers grow and potentially spread to new parts of the body, they often shed cells and DNA into the blood stream.

Posted by Andy Lundin | Nov 24, 2022 | Melanoma |

Researchers found potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to cause progression of melanoma cells.

Positive liver cancer detection data demonstrates the promise of Delfi Diagnostics’ liquid biopsy platform in a new tumor type.

A new AI blood testing tech called DELFI successfully detected more than 80% of liver cancer cases in a new study.